Immunogenicity for Biotherapeutics is the largest and longest running event designed by and for scientists dedicated to improving immunogenicity assessment for patient safety is taking pale this April in Washington DC.What are some of the workshops to look forward to this year?
-Fundamentals of Immunogenicity Assessment
Workshop Leaders: Robin Marsden, Associate Scientist, Ambrx and Edwin Golez, Amylin Pharmaceuticals
-Risk-Based Approaches to Assess Immunogenicity
Workshop Leaders: Harald Kropshofer Head & Global Coordinator, Immunosafety of Biotherapeutics, F Hoffmann-La Roche Ltd & Michele Fiscella, Associate Director, Clinical Immunology, Human Genome Sciences
-Featuring New Case Studies: Harmonization of Global SOPs for Method Development and Validation AND Multi-site Support of Global Clinical Trails
Workshop Leaders: Joseph Bower, PhD, MBA, Director, Immunochemistry, Covance, Chantilly, VA & Ian Skitt, Head of Immunochemistry, Covance, Harrogate, UK
And more!
Download the brochure to find out more about the workshops and the rest of the agenda. Register here to join us today.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment